表紙:経鼻ドラッグデリバリー技術の世界市場(2023年~2033年)
市場調査レポート
商品コード
1264064

経鼻ドラッグデリバリー技術の世界市場(2023年~2033年)

Nasal Drug Delivery Technology Market Report 2023-2033

出版日: | 発行: Visiongain Reports Ltd. | ページ情報: 英文 397 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=207.86円

ご注意:
Single UserとTeamライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

経鼻ドラッグデリバリー技術の世界市場(2023年~2033年)
出版日: 2023年04月19日
発行: Visiongain Reports Ltd.
ページ情報: 英文 397 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の経鼻ドラッグデリバリー技術の市場規模は、2022年に700億米ドルを突破し、2033年までに7.5%のCAGRで成長すると予測されています。優れたドラッグデリバリー方法に対する需要の急増、製品の包装と開発の進歩は、市場の成長を促進しています。

当レポートでは、世界の経鼻ドラッグデリバリー技術市場について調査しており、市場力学、市場動向、企業プロファイルなど、包括的な情報を提供しています。

目次

第1章 レポートの概要

第2章 エグゼクティブサマリー

第3章 市場概要

  • 主な調査結果
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
  • COVID-19の影響分析
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 競争企業間の敵対関係
    • 代替品からの脅威
    • 新規参入業者の脅威
  • PEST分析

第4章 経鼻ドラッグデリバリー技術市場分析:コンテナ別

  • 主な調査結果
  • コンテナセグメント:市場魅力指数
  • 経鼻ドラッグデリバリー技術の市場規模の推定と予測:コンテナ別
  • 加圧容器
  • 非加圧容器

第5章 経鼻ドラッグデリバリー技術市場分析:システム別

  • 主な調査結果
  • システムセグメント:市場魅力指数
  • 経鼻ドラッグデリバリー技術の市場規模の推定と予測:システム別
  • 二回用量
  • 多回用量
  • 単一用量

第6章 経鼻ドラッグデリバリー技術市場分析:剤形別

  • 主な調査結果
  • 剤形セグメント:市場魅力指数
  • 経鼻ドラッグデリバリー技術の市場規模の推定と予測:剤形別
  • 鼻腔用スプレー
  • 点鼻薬
  • 鼻腔用ジェル
  • 鼻腔用パウダー
  • その他

第7章 経鼻ドラッグデリバリー技術市場分析:用途別

  • 主な調査結果
  • 用途セグメント:市場魅力指数
  • 経鼻ドラッグデリバリー技術の市場規模の推定と予測:用途別
  • 呼吸器疾患
    • アレルギー性鼻炎
    • 鼻詰まり
    • 喘息
    • その他
  • 非呼吸器疾患
    • アルツハイマー病
    • 心血管疾患
    • 神経精神疾患
    • その他

第8章 経鼻ドラッグデリバリー技術市場分析:エンドユーザー別

  • 主な調査結果
  • エンドユーザーセグメント:市場魅力指数
  • 経鼻ドラッグデリバリー技術の市場規模の推定と予測:エンドユーザー別
  • 在宅医療
  • 病院
  • 専門クリニック
  • 予防接種センター
  • 外来手術センター
  • その他

第9章 経鼻ドラッグデリバリー技術市場分析:地域別

  • 主な調査結果
  • 市場規模の推定と予測:地域別

第10章 北米の経鼻ドラッグデリバリー技術市場分析

第11章 欧州の経鼻ドラッグデリバリー技術市場分析

第12章 アジアの経鼻ドラッグデリバリー技術市場分析

第13章 ラテンアメリカの経鼻ドラッグデリバリー技術市場分析

第14章 中東・アフリカ経鼻ドラッグデリバリー技術市場分析

第15章 企業プロファイル

  • 競合情勢(2022年)
  • 戦略の展望
  • Becton, Dickinson, and Company
  • GSK plc
  • Johnson &Johnson
  • Merck &Co., Inc
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • AptarGroup, Inc
  • AstraZeneca PLC
  • Presspart Verwaltungs GmbH
  • Recipharm AB
  • Neurelis Inc.
  • PendoPharm Inc.
  • Naveh Pharma Ltd.
  • Dr. Reddy's Laboratories
  • Pfizer Inc
  • Nemera
  • Teleflex Incorporated
  • Optinose US, Inc
  • Flo Nasal Solution
  • Bayer AG

第16章 結論と提言

  • おわりに
  • 市場関係者への推奨事項
図表

List of Tables

  • Table 1 Nasal drug delivery technology market Snapshot, 2023 & 2033 (US$ Billion, CAGR %)
  • Table 2 Nasal Drug Delivery Technology Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 3 Nasal Drug Delivery Technology Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 4 Nasal Drug Delivery Technology Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 5 Nasal Drug Delivery Technology Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 6 Nasal Drug Delivery Technology Market Forecast by Containers, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 1 Pressurized Containers and Commercial Drugs
  • Table 2 Pressurized Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 3 Non-pressurized Containers and Commercial OTC Nasal Sprays
  • Table 4 Non-Pressurized Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 5 Nasal Drug Delivery Technology Market Forecast by System, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 6 Nasal Bi Dose Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 7 Nasal Multi Dose Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 8 Nasal Uni Dose Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 9 Nasal Drug Delivery Technology Market Forecast by Dosage Form, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 2 Nasal Spray Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 3 Nasal Drops and Liquid Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 4 Nasal Gels Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 5 Nasal Powder Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 6 Others Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 7 Nasal Drug Delivery Technology Market Forecast by Application, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 8 Respiratory Disorders Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 9 Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 10 Nasal Congestion Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 11 Asthma Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 12 Other Respiratory Disorders Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 13 Non-Respiratory Disorders Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 14 Alzheimer's Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 15 Cardiovascular Disorders Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 16 Neuropsychiatry Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 17 Other Non-Respiratory Disorders Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 18 Nasal Drug Delivery Technology Market Forecast by End-users, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 19 Home Health Care Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 20 Hospitals Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 21 Specialty Clinics Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 22 Vaccination Centers Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 23 Ambulatory Surgical Centers Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 24 Others Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 25 Nasal Drug Delivery Technology Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 26 North America Nasal Drug Delivery Technology Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 27 North America Nasal Drug Delivery Technology Market Forecast by Containers, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 28 North America Nasal Drug Delivery Technology Market Forecast by System, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 29 North America Nasal Drug Delivery Technology Market Forecast by Dosage Form, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 30 North America Nasal Drug Delivery Technology Market Forecast by Application, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 31 North America Nasal Drug Delivery Technology Market Forecast by Respiratory Diseases, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 32 North America Nasal Drug Delivery Technology Market Forecast by Non-Respiratory, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 33 North America Nasal Drug Delivery Technology Market Forecast by End-users, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 34 U.S. Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 35 Canada Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 36 European Nasal Drug Delivery Technology Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 37 European Nasal Drug Delivery Technology Market Forecast by Containers, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 38 European Nasal Drug Delivery Technology Market Forecast by System, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 39 European Nasal Drug Delivery Technology Market Forecast by Dosage Form, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 40 European Nasal Drug Delivery Technology Market Forecast by Application, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 41 European Nasal Drug Delivery Technology Market Forecast by Respiratory Diseases, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 42 European Nasal Drug Delivery Technology Market Forecast by Non-Respiratory, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 43 European Nasal Drug Delivery Technology Market Forecast by End-users, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 44 Germany Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 45 UK Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 46 France Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 47 Italy Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 48 Spain Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 49 Russia Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 50 Netherlands Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 51 Switzerland Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 52 Rest of Europe Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 53 Asia Nasal Drug Delivery Technology Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 54 Asia Nasal Drug Delivery Technology Market Forecast by Containers, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 55 Asia Nasal Drug Delivery Technology Market Forecast by System, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 56 Asia Nasal Drug Delivery Technology Market Forecast by Dosage Form, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 57 Asia Nasal Drug Delivery Technology Market Forecast by Application, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 58 Asia Nasal Drug Delivery Technology Market Forecast by Respiratory Diseases, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 59 Asia Nasal Drug Delivery Technology Market Forecast by Non-Respiratory, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 60 Asia Nasal Drug Delivery Technology Market Forecast by End-users, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 61 Japan Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 62 China Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 63 India Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 64 Australia Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 65 South Korea Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 66 Singapore Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 67 Thailand Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 68 Rest of Asia Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 69 Latin America Nasal Drug Delivery Technology Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 70 Latin America Nasal Drug Delivery Technology Market Forecast by Containers, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 71 Latin America Nasal Drug Delivery Technology Market Forecast by System, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 72 Latin America Nasal Drug Delivery Technology Market Forecast by Dosage Form, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 73 Latin America Nasal Drug Delivery Technology Market Forecast by Application, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 74 Latin America Nasal Drug Delivery Technology Market Forecast by Respiratory Diseases, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 75 Latin America Nasal Drug Delivery Technology Market Forecast by Non-Respiratory, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 76 Latin America Nasal Drug Delivery Technology Market Forecast by End-users, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 77 Brazil Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 78 Mexico Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 79 Argentina Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 80 Colombia Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 81 Chile Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 82 Rest of Latin America Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 83 MEA Nasal Drug Delivery Technology Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 84 MEA Nasal Drug Delivery Technology Market Forecast by Containers, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 85 MEA Nasal Drug Delivery Technology Market Forecast by System, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 86 MEA Nasal Drug Delivery Technology Market Forecast by Dosage Form, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 87 MEA Nasal Drug Delivery Technology Market Forecast by Application, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 88 MEA Nasal Drug Delivery Technology Market Forecast by Respiratory Diseases, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 89 MEA Nasal Drug Delivery Technology Market Forecast by Non-Respiratory, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 90 MEA Nasal Drug Delivery Technology Market Forecast by End-users, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 91 GCC Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 92 South Africa Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 93 Turkey Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 94 Egypt Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 95 Rest of MEA Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 96 Strategic Outlook
  • Table 97 Becton Dickinson and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 98 AbbVie: Product Benchmarking
  • Table 99 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 100 GSK plc: Product Benchmarking
  • Table 101 Johnson & Johnson: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 102 Johnson & Johnson: Product Benchmarking
  • Table 103 Johnson & Johnson: Strategic Outlook
  • Table 104 Merck & Co. Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 105 Merck & Co., Inc: Product Benchmarking
  • Table 106 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 107 Novartis AG: Product Benchmarking
  • Table 108 Teva Pharmaceutical: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 109 Teva Pharmaceutical Industries Ltd: Product Benchmarking
  • Table 110 Teva Pharmaceutical Industries Ltd: Strategic Outlook
  • Table 111 AptarGroup Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 112 AptarGroup Inc.: Product Benchmarking
  • Table 113 AptarGroup Inc.: Strategic Outlook
  • Table 114 AstraZeneca Plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 115 AstraZeneca PLC: Product Benchmarking
  • Table 116 AstraZeneca PLC: Strategic Outlook
  • Table 117 Presspart Verwaltungs GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 118 Presspart Verwaltungs GmbH: Product Benchmarking
  • Table 119 Presspart Verwaltungs GmbH: Strategic Outlook
  • Table 120 Recipharm AB: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 121 Recipharm AB: Product Benchmarking
  • Table 122 Recipharm AB: Strategic Outlook
  • Table 123 Neurelis Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 124 Neurelis Inc: Product Benchmarking
  • Table 125 Neurelis Inc: Strategic Outlook
  • Table 126 PendoPharm Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 127 PendoPharm Inc.: Product Benchmarking
  • Table 128 Naveh Pharma Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 129 Naveh Pharma Ltd: Product Benchmarking
  • Table 130 Dr Reddy: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 131 Dr. Reddy's Laboratories: Product Benchmarking
  • Table 132 Pfizer Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 133 Pfizer Inc: Product Benchmarking
  • Table 134 Pfizer Inc: Strategic Outlook
  • Table 135 Nemera: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 136 Nemera: Product Benchmarking
  • Table 137 Nemera: Strategic Outlook
  • Table 138 Teleflex Incorporated: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 139 Teleflex Incorporated: Product Benchmarking
  • Table 140 Optinose US Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 141 Optinose US Inc: Product Benchmarking
  • Table 142 ENT Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 143 Flo Nasal Solution: Product Benchmarking
  • Table 144 Bayer AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 145 Bayer AG: Product Benchmarking

List of Figures

  • Figure 1 Nasal Drug Delivery Technology Market Segmentation
  • Figure 2 Nasal Drug Delivery Technology Market by Containers: Market Attractiveness Index
  • Figure 3 Nasal Drug Delivery Technology Market by System: Market Attractiveness Index
  • Figure 4 Nasal Drug Delivery Technology Market by Dosage Form: Market Attractiveness Index
  • Figure 5 Nasal Drug Delivery Technology Market by Application: Market Attractiveness Index
  • Figure 6 Nasal Drug Delivery Technology Market by Respiratory diseases: Market Attractiveness Index
  • Figure 7 Nasal Drug Delivery Technology Market by Non-Respiratory: Market Attractiveness Index
  • Figure 8 Nasal Drug Delivery Technology Market by End-users: Market Attractiveness Index
  • Figure 9 Nasal drug delivery technology market Attractiveness Index by Region
  • Figure 10 Nasal drug delivery technology Market: Market Dynamics
  • Figure 11 Nasal Drug Delivery Technology Market by Region, 2023-2033 (US$ Billion, AGR %): "V" Shaped Recovery
  • Figure 12 Nasal Drug Delivery Technology Market by Region, 2023-2033 (US$ Billion, AGR %): "U" Shaped Recovery
  • Figure 13 Nasal Drug Delivery Technology Market by Region, 2023-2033 (US$ Billion, AGR %): "W" Shaped Recovery
  • Figure 14 Nasal Drug Delivery Technology Market by Region, 2023-2033 (US$ Billion, AGR %): "L" Shaped Recovery
  • Figure 15 Nasal Drug Delivery Technology Market: Porter's Five Forces Analysis
  • Figure 16 Nasal Drug Delivery Technology Market: PEST Analysis
  • Figure 17 Nasal Drug Delivery Technology Market by Container: Market Attractiveness Index
  • Figure 18 Nasal Drug Delivery Technology Market Forecast by Containers, 2023-2033 (US$ Billion, AGR %)
  • Figure 19 Nasal drug delivery technology market Share Forecast by Containers, 2023, 2028, 2033 (%)
  • Figure 20 Pressurized Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 21 Pressurized Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 22 Non-Pressurized Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 23 Non-Pressurized Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 24 Nasal Drug Delivery Technology Market by System: Market Attractiveness Index
  • Figure 25 Nasal Drug Delivery Technology Market Forecast by System, 2023-2033 (US$ Billion, AGR %)
  • Figure 26 Nasal drug delivery technology market Share Forecast by System, 2023, 2028, 2033 (%)
  • Figure 27 Nasal Bi Dose Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 28 Nasal Bi Dose Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 29 Nasal Multi Dose Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 30 Nasal Multi Dose Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 31 Nasal Uni Dose Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 32 Nasal Uni Dose Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 33 Nasal Drug Delivery Technology Market by Dosage Form: Market Attractiveness Index
  • Figure 34 Nasal Drug Delivery Technology Market Forecast by Dosage Form, 2023-2033 (US$ Billion, AGR %)
  • Figure 35 Nasal drug delivery technology market Share Forecast by Dosage Form, 2023, 2028, 2033 (%)
  • Figure 36 Nasal Spray Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 37 Nasal Spray Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 38 Nasal Drops and Liquid Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 39 Nasal Drops and Liquid Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 40 Nasal Gels Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 41 Non-pressurized Containers Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 42 Nasal Powder Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 43 Nasal Powder Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 44 Others Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 45 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 46 Nasal Drug Delivery Technology Market by Application: Market Attractiveness Index
  • Figure 47 Nasal Drug Delivery Technology Market Forecast by Application, 2023-2033 (US$ Billion, AGR %)
  • Figure 48 Nasal drug delivery technology market Share Forecast by Application, 2023, 2028, 2033 (%)
  • Figure 49 Respiratory Disorders Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 50 Respiratory Disorders Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 51 Allergic Rhinitis Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 52 Allergic Rhinitis Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 53 Nasal Congestion Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 54 Nasal Congestion Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 55 Asthma Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 56 Asthma Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 57 Other Respiratory Disorders Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 58 Other Respiratory Disorders Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 59 Non-Respiratory Disorders Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 60 Non-Respiratory Disorders Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 61 Alzheimer's Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 62 Alzheimer's Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 63 Cardiovascular Disorders Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 64 Cardiovascular Disorders Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 65 Neuropsychiatry Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 66 Neuropsychiatry Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 67 Other Non-Respiratory Disorders Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 68 Other Non-Respiratory Disorders Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 69 Nasal Drug Delivery Technology Market by End-users: Market Attractiveness Index
  • Figure 70 Nasal Drug Delivery Technology Market Forecast by End-users, 2023-2033 (US$ Billion, AGR %)
  • Figure 71 Nasal drug delivery technology market Share Forecast by End-users, 2023, 2028, 2033 (%)
  • Figure 72 Home Health Care Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 73 Home Health Care Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 74 Hospitals Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 75 Hospitals Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 76 Specialty Clinics Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 77 Specialty Clinics Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 78 Vaccination Centers Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 79 Vaccination Centers Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 80 Ambulatory Surgical Centers Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 81 Ambulatory Surgical Centers Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 82 Others Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 83 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 84 Nasal Drug Delivery Technology Market Forecast by Region 2023 and 2033 (Revenue, CAGR%)
  • Figure 85 Nasal drug delivery technology market Share Forecast by Region 2023, 2028, 2033 (%)
  • Figure 86 Nasal Drug Delivery Technology Market by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 87 North America Nasal Drug Delivery Technology Market Attractiveness Index
  • Figure 88 North America Nasal Drug Delivery Technology Market by Region, 2023, 2028 & 2033 (US$ Billion)
  • Figure 89 North America Nasal Drug Delivery Technology Market Forecast by Country, 2023-2033 (US$ Billion, AGR %)
  • Figure 90 North America Nasal Drug Delivery Technology Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 91 North America Nasal Drug Delivery Technology Market Forecast by Containers, 2023-2033 (US$ Billion, AGR %)
  • Figure 92 North America Nasal Drug Delivery Technology Market Share Forecast by Containers, 2023 & 2033 (%)
  • Figure 93 North America Nasal Drug Delivery Technology Market Forecast by System, 2023-2033 (US$ Billion, AGR %)
  • Figure 94 North America Nasal Drug Delivery Technology Market Share Forecast by System, 2023 & 2033 (%)
  • Figure 95 North America Nasal Drug Delivery Technology Market Forecast by Dosage Form, 2023-2033 (US$ Billion, AGR %)
  • Figure 96 North America Nasal Drug Delivery Technology Market Share Forecast by Dosage Form, 2023 & 2033 (%)
  • Figure 97 North America Nasal Drug Delivery Technology Market Forecast by Application, 2023-2033 (US$ Billion, AGR %)
  • Figure 98 North America Nasal Drug Delivery Technology Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 99 North America Nasal Drug Delivery Technology Market Forecast by Respiratory Diseases, 2023-2033 (US$ Billion, AGR %)
  • Figure 100 North America Nasal Drug Delivery Technology Market Share Forecast by Respiratory Diseases, 2023 & 2033 (%)
  • Figure 101 North America Nasal Drug Delivery Technology Market Forecast by Non-respiratory Diseases, 2023-2033 (US$ Billion, AGR %)
  • Figure 102 North America Nasal Drug Delivery Technology Market Share Forecast by Non-respiratory Diseases, 2023 & 2033 (%)
  • Figure 103 North America Nasal Drug Delivery Technology Market Forecast by End-users, 2023-2033 (US$ Billion, AGR %)
  • Figure 104 North America Nasal Drug Delivery Technology Market Share Forecast by End-users, 2023 & 2033 (%)
  • Figure 105 U.S. Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 106 Canada Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 107 European Nasal Drug Delivery Technology Market Attractiveness Index
  • Figure 108 European Nasal Drug Delivery Technology Market by Region, 2023, 2028 & 2033 (US$ Billion)
  • Figure 109 European Nasal Drug Delivery Technology Market Forecast by Country, 2023-2033 (US$ Billion, AGR %)
  • Figure 110 European Nasal Drug Delivery Technology Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 111 European Nasal Drug Delivery Technology Market Forecast by Containers, 2023-2033 (US$ Billion, AGR %)
  • Figure 112 European Nasal Drug Delivery Technology Market Share Forecast by Containers, 2023 & 2033 (%)
  • Figure 113 European Nasal Drug Delivery Technology Market Forecast by System, 2023-2033 (US$ Billion, AGR %)
  • Figure 114 European Nasal Drug Delivery Technology Market Share Forecast by System, 2023 & 2033 (%)
  • Figure 115 European Nasal Drug Delivery Technology Market Forecast by Dosage Form, 2023-2033 (US$ Billion, AGR %)
  • Figure 116 European Nasal Drug Delivery Technology Market Share Forecast by Dosage Form, 2023 & 2033 (%)
  • Figure 117 European Nasal Drug Delivery Technology Market Forecast by Application, 2023-2033 (US$ Billion, AGR %)
  • Figure 118 European Nasal Drug Delivery Technology Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 119 European Nasal Drug Delivery Technology Market Forecast by Respiratory Diseases, 2023-2033 (US$ Billion, AGR %)
  • Figure 120 European Nasal Drug Delivery Technology Market Share Forecast by Respiratory Diseases, 2023 & 2033 (%)
  • Figure 121 European Nasal Drug Delivery Technology Market Forecast by Non-respiratory Diseases, 2023-2033 (US$ Billion, AGR %)
  • Figure 122 European Nasal Drug Delivery Technology Market Share Forecast by Non-respiratory Diseases, 2023 & 2033 (%)
  • Figure 123 European Nasal Drug Delivery Technology Market Forecast by End-users, 2023-2033 (US$ Billion, AGR %)
  • Figure 124 European Nasal Drug Delivery Technology Market Share Forecast by End-users, 2023 & 2033 (%)
  • Figure 125 Germany Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 126 UK Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 127 France Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 128 Italy Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 129 Spain Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 130 Russia Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 131 Netherlands Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 132 Switzerland Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 133 Rest of Europe Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 134 Asia Nasal Drug Delivery Technology Market Attractiveness Index
  • Figure 135 Asia Nasal Drug Delivery Technology Market by Region, 2023, 2028 & 2033 (US$ Billion)
  • Figure 136 Asia Nasal Drug Delivery Technology Market Forecast by Country, 2023-2033 (US$ Billion, AGR %)
  • Figure 137 Asia Nasal Drug Delivery Technology Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 138 Asia Nasal Drug Delivery Technology Market Forecast by Containers, 2023-2033 (US$ Billion, AGR %)
  • Figure 139 Asia Nasal Drug Delivery Technology Market Share Forecast by Containers, 2023 & 2033 (%)
  • Figure 140 Asia Nasal Drug Delivery Technology Market Forecast by System, 2023-2033 (US$ Billion, AGR %)
  • Figure 141 Asia Nasal Drug Delivery Technology Market Share Forecast by System, 2023 & 2033 (%)
  • Figure 142 Asia Nasal Drug Delivery Technology Market Forecast by Dosage Form, 2023-2033 (US$ Billion, AGR %)
  • Figure 143 Asia Nasal Drug Delivery Technology Market Share Forecast by Dosage Form, 2023 & 2033 (%)
  • Figure 144 Asia Nasal Drug Delivery Technology Market Forecast by Application, 2023-2033 (US$ Billion, AGR %)
  • Figure 145 Asia Nasal Drug Delivery Technology Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 146 Asia Nasal Drug Delivery Technology Market Forecast by Respiratory Diseases, 2023-2033 (US$ Billion, AGR %)
  • Figure 147 Asia Nasal Drug Delivery Technology Market Share Forecast by Respiratory Diseases, 2023 & 2033 (%)
  • Figure 148 Asia Nasal Drug Delivery Technology Market Forecast by Non-respiratory Diseases, 2023-2033 (US$ Billion, AGR %)
  • Figure 149 Asia Nasal Drug Delivery Technology Market Share Forecast by Non-respiratory Diseases, 2023 & 2033 (%)
  • Figure 150 Asia Nasal Drug Delivery Technology Market Forecast by End-users, 2023-2033 (US$ Billion, AGR %)
  • Figure 151 Asia Nasal Drug Delivery Technology Market Share Forecast by End-users, 2023 & 2033 (%)
  • Figure 152 Japan Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 153 China Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 154 India Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 155 Australia Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 156 South Korea Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 157 Singapore Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 158 Thailand Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 159 Rest of Asia Nasal Drug Delivery Technology Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 160 Latin America Nasal Drug Delivery Technology Market Attractiveness Index
  • Figure 161 Latin America Nasal Drug Delivery Technology Market by Region, 2023, 2028 & 2033 (US$ Billion)
  • Figure 162 Latin America Nasal Drug Delivery Technology Market Forecast by Country, 2023-2033 (US$ Billion, AGR %)
  • Figure 163 Latin America Nasal Drug Delivery Technology Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 164 Latin America Nasal Drug Delivery Technology Market Forecast by Containers, 2023-2033 (US$ Billion, AGR %)
  • Figure 165 Latin America Nasal Drug Delivery Technology Market Share Forecast by Containers, 2023 & 2033 (%)
  • Figure 166 Latin America Nasal Drug Delivery Technology Market Forecast by System, 2023-2033 (US$ Billion, AGR %)
  • Figure 167 Latin America Nasal Drug Delivery Technology Market Share Forecast by System, 2023 & 2033 (%)
  • Figure 168 Latin America Nasal Drug Delivery Technology Market Forecast by Dosage Form, 2023-2033 (US$ Billion, AGR %)
  • Figure 169 Latin America Nasal Drug Delivery Technology Market Share Forecast by Dosage Form, 2023 & 2033 (%)
  • Figure 170 Latin America Nasal Drug Delivery Technology Market Forecast by Application, 2023-2033 (US$ Billion, AGR %)
  • Figure 171 Latin America Nasal Drug Delivery Technology Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 172 Latin America Nasal Drug Delivery Technology Market Forecast by Respiratory Diseases, 2023-2033 (US$ Billion, AGR %)
  • Figure 173 Latin America Nasal Drug Delivery Technology Market Share Forecast by Respiratory Diseases, 2023 & 2033 (%)
目次
Product Code: PHA1251

The global Nasal Drug Delivery Technology market is projected to grow at a CAGR of 7.5% by 2033

The Nasal Drug Delivery Technology Market Report 2022-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Demand for Alternative Drug Delivery Methods Coupled with Advancements In Product Development Driving Market Growth

Some of the major forces propelling the nasal drug delivery technology market include surge in demand for better drug delivery methods, and advancements in product packing and development. Furthermore, rising prevalence of allergic rhinitis and increasing cases of asthma are expected to propel market growth. On the other hand, rise in adoption of generic nasal delivery drugs coupled with new launches are expected to further boost market growth. Developing a successful nasal drug product requires expertise in a variety of areas, including formulation development, device design, clinical trial design, regulatory compliance, and commercialization. Market players are entering into strategic partnerships such as agreement and mergers to meet the growing market demand for effective nasal drugs. Many pharmaceutical companies developing a nasal drug product are partnering with a device manufacturer to design and manufacture a nasal delivery device that is optimized for the specific drug formulation.

On the other hand, production of pharmaceutical products is subject to strict consumer safety regulations. Before a product is finally marketed, lengthy and laborious processes are typically required for medical device and medicine approvals. Companies who engage in significant R&D to introduce new items to the market typically find this to be a hurdle. These stringent regulations are anticipated to hinder the growth of this market over the forecast period.

Complications with Nasal Drug Overuse Likely to Challenge Market Growth

Overuse of nasal drugs can lead to a variety of side effects, some of which can be serious. Rebound congestion, nosebleed, and irritation of nasal membrane are some of the side effects of nasal spray overuse. Many people mistakenly believe that nasal sprays are safe to use since they are widely accessible as over-the-counter medications, and they are ignorant of the potential side effects and addiction linked to them. Regular nasal spray users are prone to developing a habit of abusing the medicine. When their symptoms get worse, people take the prescription more frequently, which frequently results in rhinitis medicamentosa, a disorder. This frequently leads to a condition known as septal perforation-a hole in the inner wall of the nose-in situations of misuse.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the Nasal Drug Delivery Technology Market evolving?
  • What is driving and restraining the nasal drug delivery technology market?
  • How will each nasal drug delivery technology submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each nasal drug delivery technology submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading nasal drug delivery technology markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the nasal drug delivery technology projects for these leading companies?
  • How will the industry evolve during the period between 2022 and 2033? What are the implications of nasal drug delivery technology projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the nasal drug delivery technology market?
  • Where is the nasal drug delivery technology market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the nasal drug delivery technology market today, and over the next 10 years:

  • Our 397-page report provides 141 tables and 251 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Nasal Drug Delivery Technology Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising nasal drug delivery technology prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report

Container

  • Pressurized Containers
  • Non-pressurized Containers

System

  • Nasal Bi Dose
  • Nasal Multi Dose
  • Nasal Unidose

Dosage Form

  • Nasal Spray
  • Nasal Drops and Liquids
  • Nasal Gels
  • Nasal Powder
  • Others

Application

  • Respiratory Diseases

Allergic Rhinitis

Nasal Congestion

Asthma

Others

  • Non-respiratory Diseases

Alzheimer's

Cardiovascular Disorders

Neuropsychiatry

Others

End-users

  • Home Health Care
  • Hospitals
  • Specialty Clinics
  • Vaccination Centres
  • Ambulatory Surgical Centres
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 29 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Switzerland
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
  • Thailand
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Turkey
  • Egypt
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Nasal Drug Delivery Technology Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

  • AptarGroup, Inc
  • AstraZeneca PLC
  • Bayer AG
  • Becton, Dickinson, and Company
  • Dr. Reddy's Laboratories Ltd.
  • Flo Nasal Solution
  • GlaxoSmithKline PLC
  • H&T Presspart
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Naveh Pharma Ltd
  • Nemera
  • Novartis AG
  • Neurelis Inc.
  • OptiNose, Inc.
  • Pfizer Inc.
  • PendoPharm Inc.
  • Recipharm AB
  • Teleflex, Inc.
  • Teva Pharmaceutical Industries Ltd.

Overall world revenue for Nasal Drug Delivery Technology Market, 2023 to 2033 in terms of value the market will surpass US$70 billion in 2022, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Nasal Drug Delivery Technology Market, 2023 to 2033 report help you?

In summary, our 397-page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for Nasal Drug Delivery Technology Market, 2023 to 2033 Market, with forecasts for containers, system, dosage form, application, end user, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 30 key national markets - See forecasts for the Nasal Drug Delivery Technology Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 20 of the major companies involved in the Nasal Drug Delivery Technology Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Nasal Drug Delivery Technology Market, 2023 to 2033, market-leading companies. You will find data, trends, and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Nasal drug delivery technology market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 High Prevalence of Allergic Rhinitis to Spur Demand
      • 3.2.1.2 Multiple Benefits Associated with Multi-dose Nasal Spray Packaging to Boost Industry Growth
      • 3.2.1.3 Chronic Respiratory Diseases Driving Market Growth
      • 3.2.1.4 Need for Generic Inhalation and Nasal Spray Drugs to Boost Industry Growth
      • 3.2.1.5 Support from Government and NGOs for Respiratory Diseases Healthcare Awareness to Spur Market Growth
      • 3.2.1.6 Advanced Inhalation Methods to Augment Market Growth
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Product Development Regulations Likely to Restrain Market Growth
      • 3.2.2.2 Complications Associated with the Overuse of Nasal Sprays
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Emerging Opportunities for Nasal Devices
      • 3.2.3.2 Nasal Drug Delivery Has Evolved into a Highly Versatile Method of Administration for Locally Acting And Systemic Drugs
      • 3.2.3.3 Rising Demand for Generic Drugs is Expected to Enhance Market Growth
      • 3.2.3.4 DPI Technology Driving the Adoption of Nasal Drugs
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat from Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Nasal Drug Delivery Technology Market Analysis by Containers

  • 4.1 Key Findings
  • 4.2 Container Segment: Market Attractiveness Index
  • 4.3 Nasal Drug Delivery Technology Market Size Estimation and Forecast by Containers
  • 4.4 Pressurized Containers
    • 4.4.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5 Non-pressurized Containers
    • 4.5.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 4.5.2 Market Share by Region, 2023 & 2033 (%)

5 Nasal Drug Delivery Technology Market Analysis by System

  • 5.1 Key Findings
  • 5.2 System Segment: Market Attractiveness Index
  • 5.3 Nasal Drug Delivery Technology Market Size Estimation and Forecast by System
  • 5.4 Nasal Bi Dose
    • 5.4.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 5.4.2 Market Share by Region, 2023 & 2033 (%)
  • 5.5 Nasal Multi Dose
    • 5.5.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 5.5.2 Market Share by Region, 2023 & 2033 (%)
  • 5.6 Nasal Unidose
    • 5.6.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 5.6.2 Market Share by Region, 2023 & 2033 (%)

6 Nasal Drug Delivery Technology Market Analysis By Dosage Form

  • 6.1 Key Findings
  • 6.2 Dosage Form Segment: Market Attractiveness Index
  • 6.3 Nasal Drug Delivery Technology Market Size Estimation and Forecast by Dosage Form
  • 6.4 Nasal Spray
    • 6.4.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 6.4.2 Market Share by Region, 2023 & 2033 (%)
  • 6.5 Nasal Drops and Liquid
    • 6.5.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 6.5.2 Market Share by Region, 2023 & 2033 (%)
  • 6.6 Nasal Gels
    • 6.6.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 6.6.2 Market Share by Region, 2023 & 2033 (%)
  • 6.7 Nasal Powder
    • 6.7.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 6.7.2 Market Share by Region, 2023 & 2033 (%)
  • 6.8 Others
    • 6.8.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 6.8.2 Market Share by Region, 2023 & 2033 (%)

7 Nasal Drug Delivery Technology Market Analysis by Application

  • 7.1 Key Findings
  • 7.2 Application Segment: Market Attractiveness Index
  • 7.3 Nasal Drug Delivery Technology Market Size Estimation and Forecast by Application
  • 7.4 Respiratory Diseases
    • 7.4.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 7.4.2 Market Share by Region, 2023 & 2033 (%)
    • 7.4.3 Allergic Rhinitis
      • 7.4.3.1 Market Size by Region, 2023-2033 (US$ Billion)
      • 7.4.3.2 Market Share by Region, 2023 & 2033 (%)
    • 7.4.4 Nasal Congestion
      • 7.4.4.1 Market Size by Region, 2023-2033 (US$ Billion)
      • 7.4.4.2 Market Share by Region, 2023 & 2033 (%)
    • 7.4.5 Asthma
      • 7.4.5.1 FDA Approved First Generic of Symbicort to Treat Asthma and COPD
      • 7.4.5.2 Market Size by Region, 2023-2033 (US$ Billion)
      • 7.4.5.3 Market Share by Region, 2023 & 2033 (%)
    • 7.4.6 Others
      • 7.4.6.1 COPD
      • 7.4.6.2 Lupin Launched Nasal Drug For Breathing Problems In United States
      • 7.4.6.3 Covid 19
      • 7.4.6.4 Market Size by Region, 2023-2033 (US$ Billion)
      • 7.4.6.5 Market Share by Region, 2023 & 2033 (%)
  • 7.5 Non-respiratory Diseases
    • 7.5.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 7.5.2 Market Share by Region, 2023 & 2033 (%)
    • 7.5.3 Alzheimer's
      • 7.5.3.1 Market Size by Region, 2023-2033 (US$ Billion)
      • 7.5.3.2 Market Share by Region, 2023 & 2033 (%)
    • 7.5.4 Cardiovascular Disorders
      • 7.5.4.1 Market Size by Region, 2023-2033 (US$ Billion)
      • 7.5.4.2 Market Share by Region, 2023 & 2033 (%)
    • 7.5.5 Neuropsychiatry
      • 7.5.5.1 Market Size by Region, 2023-2033 (US$ Billion)
      • 7.5.5.2 Market Share by Region, 2023 & 2033 (%)
    • 7.5.6 Others
      • 7.5.6.1 Market Size by Region, 2023-2033 (US$ Billion)
      • 7.5.6.2 Market Share by Region, 2023 & 2033 (%)

8 Nasal Drug Delivery Technology Market Analysis by End-users

  • 8.1 Key Findings
  • 8.2 End-users Segment: Market Attractiveness Index
  • 8.3 Nasal Drug Delivery Technology Market Size Estimation and Forecast by End-users
  • 8.4 Home Health Care
    • 8.4.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 8.4.2 Market Share by Region, 2023 & 2033 (%)
  • 8.5 Hospitals
    • 8.5.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 8.5.2 Market Share by Region, 2023 & 2033 (%)
  • 8.6 Speciality Clinics
    • 8.6.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 8.6.2 Market Share by Region, 2023 & 2033 (%)
  • 8.7 Vaccination Centres
    • 8.7.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 8.7.2 Market Share by Region, 2023 & 2033 (%)
  • 8.8 Ambulatory Surgical Centres
    • 8.8.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 8.8.2 Market Share by Region, 2023 & 2033 (%)
  • 8.9 Others
    • 8.9.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 8.9.2 Market Share by Region, 2023 & 2033 (%)

9 Nasal Drug Delivery Technology Market Analysis by Region

  • 9.1 Key Findings
  • 9.2 Regional Market Size Estimation and Forecast

10 North America Nasal Drug Delivery Technology Market Analysis

  • 10.1 Key Findings
  • 10.2 North America Nasal Drug Delivery Technology Market Attractiveness Index
  • 10.3 North America Nasal Drug Delivery Technology Market by Country, 2023, 2028 & 2033 (US$ Billion)
  • 10.4 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Country
  • 10.5 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Containers
  • 10.6 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by System
  • 10.7 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Dosage Form
  • 10.8 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Application
  • 10.9 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Respiratory Diseases
  • 10.10 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Non-respiratory Diseases
  • 10.11 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by End-users
  • 10.12 U.S. Nasal Drug Delivery Technology Market Analysis
  • 10.13 Canada Nasal Drug Delivery Technology Market Analysis

11 European Nasal Drug Delivery Technology Market Analysis

  • 11.1 Key Findings
  • 11.2 European Nasal Drug Delivery Technology Market Attractiveness Index
  • 11.3 European Nasal Drug Delivery Technology Market by Country, 2023, 2028 & 2033 (US$ Billion)
  • 11.4 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by Country
  • 11.5 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by Containers
  • 11.6 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by System
  • 11.7 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by Dosage Form
  • 11.8 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by Application
  • 11.9 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by Respiratory Diseases
  • 11.10 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by Non-respiratory Diseases
  • 11.11 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by End-users
  • 11.12 Germany Nasal Drug Delivery Technology Market Analysis
  • 11.13 UK Nasal Drug Delivery Technology Market Analysis
  • 11.14 France Nasal Drug Delivery Technology Market Analysis
  • 11.15 Italy Nasal Drug Delivery Technology Market Analysis
  • 11.16 Spain Nasal Drug Delivery Technology Market Analysis
  • 11.17 Russia Nasal Drug Delivery Technology Market Analysis
  • 11.18 Netherlands Nasal Drug Delivery Technology Market Analysis
  • 11.19 Switzerland Nasal Drug Delivery Technology Market Analysis
  • 11.20 Rest of Europe Nasal Drug Delivery Technology Market Analysis

12 Asia Nasal Drug Delivery Technology Market Analysis

  • 12.1 Key Findings
  • 12.2 Asia Nasal Drug Delivery Technology Market Attractiveness Index
  • 12.3 Asia Nasal Drug Delivery Technology Market by Country, 2023, 2028 & 2033 (US$ Billion)
  • 12.4 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by Country
  • 12.5 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by Containers
  • 12.6 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by System
  • 12.7 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by Dosage Form
  • 12.8 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by Application
  • 12.9 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by Respiratory Diseases
  • 12.10 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by Non-respiratory Diseases
  • 12.11 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by End-users
  • 12.12 Japan Nasal Drug Delivery Technology Market Analysis
  • 12.13 China Nasal Drug Delivery Technology Market Analysis
  • 12.14 India Nasal Drug Delivery Technology Market Analysis
  • 12.15 Australia Nasal Drug Delivery Technology Market Analysis
  • 12.16 South Korea Nasal Drug Delivery Technology Market Analysis
  • 12.17 Singapore Nasal Drug Delivery Technology Market Analysis
  • 12.18 Thailand Nasal Drug Delivery Technology Market Analysis
  • 12.19 Rest of Asia Nasal Drug Delivery Technology Market Analysis

13 Latin America Nasal Drug Delivery Technology Market Analysis

  • 13.1 Key Findings
  • 13.2 Latin America Nasal Drug Delivery Technology Market Attractiveness Index
  • 13.3 Latin America Nasal Drug Delivery Technology Market by Country, 2023, 2028 & 2033 (US$ Billion)
  • 13.4 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Country
  • 13.5 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Containers
  • 13.6 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by System
  • 13.7 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Dosage Form
  • 13.8 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Application
  • 13.9 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Respiratory Diseases
  • 13.10 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Non-respiratory Diseases
  • 13.11 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by End-users
  • 13.12 Brazil Nasal Drug Delivery Technology Market Analysis
  • 13.13 Mexico Nasal Drug Delivery Technology Market Analysis
  • 13.14 Argentina Nasal Drug Delivery Technology Market Analysis
  • 13.15 Colombia Nasal Drug Delivery Technology Market Analysis
  • 13.16 Chile Nasal Drug Delivery Technology Market Analysis
  • 13.17 Rest of Latin America Nasal Drug Delivery Technology Market Analysis

14 MEA Nasal Drug Delivery Technology Market Analysis

  • 14.1 Key Findings
  • 14.2 MEA Nasal Drug Delivery Technology Market Attractiveness Index
  • 14.3 MEA Nasal Drug Delivery Technology Market by Country, 2023, 2028 & 2033 (US$ Billion)
  • 14.4 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by Country
  • 14.5 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by Containers
  • 14.6 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by System
  • 14.7 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by Dosage Form
  • 14.8 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by Application
  • 14.9 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by Respiratory Diseases
  • 14.10 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by Non-respiratory Diseases
  • 14.11 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by End-users
  • 14.12 GCC Nasal Drug Delivery Technology Market Analysis
  • 14.13 South Africa Nasal Drug Delivery Technology Market Analysis
  • 14.14 Turkey Nasal Drug Delivery Technology Market Analysis
  • 14.15 Egypt Nasal Drug Delivery Technology Market Analysis
  • 14.16 Rest of MEA Nasal Drug Delivery Technology Market Analysis

15 Company Profiles

  • 15.1 Competitive Landscape, 2022
  • 15.2 Strategic Outlook
  • 15.3 Becton, Dickinson, and Company
    • 15.3.1 Company Snapshot
    • 15.3.2 Company Overview
    • 15.3.3 Financial Analysis
      • 15.3.3.1 Net Revenue, 2017-2022
      • 15.3.3.2 R&D, 2017-2022
      • 15.3.3.3 Regional Market Shares, 2022
      • 15.3.3.4 Segment Market Shares, 2022
    • 15.3.4 Product Benchmarking
  • 15.4 GSK plc
    • 15.4.1 Company Snapshot
    • 15.4.2 Company Overview
    • 15.4.3 Financial Analysis
      • 15.4.3.1 Net Revenue, 2017-2022
      • 15.4.3.2 R&D, 2017-2022
      • 15.4.3.3 Regional Market Shares, 2022
      • 15.4.3.4 Business Segment Market Shares, 2022
    • 15.4.4 Product Benchmarking
  • 15.5 Johnson & Johnson
    • 15.5.1 Company Snapshot
    • 15.5.2 Company Overview
    • 15.5.3 Financial Analysis
      • 15.5.3.1 Net Revenue, 2017-2022
      • 15.5.3.2 R&D, 2017-2022
      • 15.5.3.3 Regional Market Shares, 2022
      • 15.5.3.4 Business Segment Market Shares, 2022
    • 15.5.4 Product Benchmarking
    • 15.5.5 Strategic Outlook
  • 15.6 Merck & Co., Inc
    • 15.6.1 Company Snapshot
    • 15.6.2 Company Overview
    • 15.6.3 Financial Analysis
      • 15.6.3.1 Net Revenue, 2017-2022
      • 15.6.3.2 R&D, 2017-2022
      • 15.6.3.3 Regional Market Shares, 2022
      • 15.6.3.4 Business Segment Market Shares, 2022
    • 15.6.4 Product Benchmarking
  • 15.7 Novartis AG
    • 15.7.1 Company Snapshot
    • 15.7.2 Company Overview
    • 15.7.3 Financial Analysis
      • 15.7.3.1 Net Revenue, 2017-2022
      • 15.7.3.2 R&D, 2017-2022
      • 15.7.3.3 Regional Market Shares, 2022
      • 15.7.3.4 Business Segment Market Shares, 2022
    • 15.7.4 Product Benchmarking
  • 15.8 Teva Pharmaceutical Industries Ltd.
    • 15.8.1 Company Snapshot
    • 15.8.2 Company Overview
    • 15.8.3 Financial Analysis
      • 15.8.3.1 Net Revenue, 2017-2022
      • 15.8.3.2 R&D, 2017-2022
      • 15.8.3.3 Regional Market Shares, 2022
      • 15.8.3.4 Business Segment Market Shares, 2022
    • 15.8.4 Product Benchmarking
    • 15.8.5 Strategic Outlook
  • 15.9 AptarGroup, Inc
    • 15.9.1 Company Snapshot
    • 15.9.2 Company Overview
    • 15.9.3 Financial Analysis
      • 15.9.3.1 Net Revenue, 2017-2022
      • 15.9.3.2 R&D, 2017-2022
      • 15.9.3.3 Regional Market Shares, 2022
      • 15.9.3.4 Business Segment Market Shares, 2022
    • 15.9.4 Product Benchmarking
    • 15.9.5 Strategic Outlook
  • 15.10 AstraZeneca PLC
    • 15.10.1 Company Snapshot
    • 15.10.2 Company Overview
    • 15.10.3 Financial Analysis
      • 15.10.3.1 Net Revenue, 2017-2022
      • 15.10.3.2 R&D, 2017-2022
      • 15.10.3.3 Regional Market Shares, 2022
      • 15.10.3.4 Business Segment Market Shares, 2022
    • 15.10.4 Product Benchmarking
    • 15.10.5 Strategic Outlook
  • 15.11 Presspart Verwaltungs GmbH
    • 15.11.1 Company Snapshot
    • 15.11.2 Company Overview
    • 15.11.3 Product Benchmarking
    • 15.11.4 Strategic Outlook
  • 15.12 Recipharm AB
    • 15.12.1 Company Snapshot
    • 15.12.2 Company Overview
    • 15.12.3 Product Benchmarking
    • 15.12.4 Strategic Outlook
  • 15.13 Neurelis Inc.
    • 15.13.1 Company Snapshot
    • 15.13.2 Overview
    • 15.13.3 Product Benchmarking
    • 15.13.4 Strategic Outlook
  • 15.14 PendoPharm Inc.
    • 15.14.1 Company Snapshot
    • 15.14.2 Company Overview
    • 15.14.3 Product Benchmarking
  • 15.15 Naveh Pharma Ltd.
    • 15.15.1 Company Snapshot
    • 15.15.2 Company Overview
    • 15.15.3 Product Benchmarking
  • 15.16 Dr. Reddy's Laboratories
    • 15.16.1 Company Snapshot
    • 15.16.2 Company Overview
    • 15.16.3 Financial Analysis
      • 15.16.3.1 Net Revenue, 2017-2022
      • 15.16.3.2 R&D, 2017-2022
      • 15.16.3.3 Regional Market Shares, 2022
      • 15.16.3.4 Business Segment Market Shares, 2022
    • 15.16.4 Product Benchmarking
  • 15.17 Pfizer Inc
    • 15.17.1 Company Snapshot
    • 15.17.2 Company Overview
    • 15.17.3 Financial Analysis
      • 15.17.3.1 Net Revenue, 2017-2022
      • 15.17.3.2 R&D, 2017-2022
      • 15.17.3.3 Regional Market Shares, 2022
      • 15.17.3.4 Business Segment Market Shares, 2022
    • 15.17.4 Product Benchmarking
    • 15.17.5 Strategic Outlook
  • 15.18 Nemera
    • 15.18.1 Company Snapshot
    • 15.18.2 Company Overview
    • 15.18.3 Product Benchmarking
    • 15.18.4 Strategic Outlook
  • 15.19 Teleflex Incorporated
    • 15.19.1 Company Snapshot
    • 15.19.2 Company Overview
    • 15.19.3 Product Benchmarking
  • 15.20 Optinose US, Inc
    • 15.20.1 Company Snapshot
    • 15.20.2 Company Overview
    • 15.20.3 Product Benchmarking
  • 15.21 Flo Nasal Solution
    • 15.21.1 Company Snapshot
    • 15.21.2 Company Overview
    • 15.21.3 Product Benchmarking
  • 15.22 Bayer AG
    • 15.22.1 Company Snapshot
    • 15.22.2 Company Overview
    • 15.22.3 Financial Analysis
      • 15.22.3.1 Net Revenue, 2017-2022
      • 15.22.3.2 R&D, 2017-2022
      • 15.22.3.3 Regional Market Shares, 2022
      • 15.22.3.4 Business Segment Market Shares, 2022
    • 15.22.4 Product Benchmarking

16 Conclusion and Recommendations

  • 16.1 Concluding Remarks from
  • 16.2 Recommendations for Market Players